CG
CG Oncology
CGON·NASDAQIrvine CAFounded 2010130 employees
Mid CapbiotechPublicOncology
Platform: Oncolytic Ad
Market Cap
$3B
All Drugs
3
Clinical Trials
9
Failed / Terminated
1
FDA Approved
1
Stock Price & Catalysts (CGON)
Loading CGON stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| CGO-2579 | CGO-2579 | Approved | 4 | TIGIT | Hemophilia ARSV | ||
| CGO-9628 | CGO-9628 | Phase 2/3 | 1 | AuroraA | CLLFabry | ||
| Tezetapinarof | CGO-6895 | Phase 3 | 4 | VEGF | FTD |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (9)